1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Force Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. NORTH AMERICA TRANSPLANT MARKET, BY TYPE
5.1. Introduction
5.2. Tissue Transplant
5.3. Organ Transplant
5.3.1. Living Donors
5.3.2. Deceased Donors
6. NORTH AMERICA TRANSPLANT MARKET, BY PROCEDURE
6.1. Introduction
6.2. Autotransplantation
6.3. Allotransplantation
6.4. Xenotransplantation
7. NORTH AMERICA TRANSPLANT MARKET, BY PRODUCT
7.1. Introduction
7.2. Immunosuppresive drugs
7.3. Preservation Solutions
7.4. Organ Transport Systems
8. NORTH AMERICA TRANSPLANT MARKET, BY COUNTRY
8.1. Introduction
8.2. United States
8.3. Canada
8.4. Mexico
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. Veloxis Pharmaceuticals, Inc.
10.2. Bridge to Life Ltd.
10.3. Paragonix Technologies Inc.
10.4. Global Transplant Solutions
10.5. XVIVO Perfusion
10.6. Novartis Pharmaceuticals Corporation
10.7. TransMedics, Inc.